First human tests begin for new COPD drug candidate
NCT ID NCT06908642
Summary
This early-stage study tested the safety of a new tablet called Hemay005 in healthy volunteers. Researchers wanted to see if different ways of giving the first doses affected how many side effects people experienced. The goal was to gather basic safety information before testing the drug in people with chronic lung disease (COPD).
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Affiliated Hospital of Wannan Medical College
Wuhu, Anhui, 241000, China
Conditions
Explore the condition pages connected to this study.